|
1
|
Krausz C and Forti G: Clinical aspects of
male infertility. Results Probl Cell Differ. 28:1–21. 2000.
View Article : Google Scholar
|
|
2
|
Huynh T, Mollard R and Trounson A:
Selected genetic factors associated with male infertility. Hum
Reprod Update. 8:183–198. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jamsai D, Reilly A, Smith SJ, et al:
Polymorphisms in the human cysteine-rich secretory protein 2
(CRISP2) gene in Australian men. Hum Reprod. 23:2151–2159. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Moore HD and Akhondi MA: In vitro
maturation of mammalian spermatozoa. Rev Reprod. 1:54–60. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Viger RS and Robaire B: Steady state
steroid 5 alpha-reductase messenger ribonucleic acid levels and
immunocytochemical localization of the type 1 protein in the rat
testis during postnatal development. Endocrinology. 136:5409–5415.
1995.
|
|
6
|
Steinberger E: Hormonal control of
mammalian spermatogenesis. Physiol Rev. 51:1–22. 1971.
|
|
7
|
Sultan C, Lumbroso S, Paris F, et al:
Disorders of androgen action. Semin Reprod Med. 20:217–228. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Makridakis NM, di Salle E and Reichardt
JK: Biochemical and pharmacogenetic dissection of human steroid 5
alpha-reductase type II. Pharmacogenetics. 10:407–413. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Debes JD and Tindall DJ: Mechanisms of
androgen-refractory prostate cancer. N Engl J Med. 351:1488–1490.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Can S, Zhu YS, Cai LQ, et al: The
identification of 5 alpha-reductase-2 and 17 beta-hydroxysteroid
dehydrogenase-3 gene defects in male pseudohermaphrodites from a
Turkish kindred. J Clin Endocrinol Metab. 83:560–569.
1998.PubMed/NCBI
|
|
11
|
Fernandez-Cancio M, Nistal M, Gracia R, et
al: Compound heterozygous mutations in the SRD5A2 gene exon 4 in a
male pseudohermaphrodite patient of Chinese origin. J Androl.
25:412–416. 2004.PubMed/NCBI
|
|
12
|
Chavez B, Valdez E and Vilchis F:
Uniparental disomy in steroid 5alpha-reductase 2 deficiency. J Clin
Endocrinol Metab. 85:3147–3150. 2000.PubMed/NCBI
|
|
13
|
Makridakis N, Ross RK, Pike MC, et al: A
prevalent missense substitution that modulates activity of
prostatic steroid 5alpha-reductase. Cancer Res. 57:1020–1022.
1997.PubMed/NCBI
|
|
14
|
Allen NE, Forrest MS and Key TJ: The
association between polymorphisms in the CYP17 and 5alpha-reductase
(SRD5A2) genes and serum androgen concentrations in men. Cancer
Epidemiol Biomarkers Prev. 10:185–189. 2001.PubMed/NCBI
|
|
15
|
Hayes VM, Severi G, Padilla EJ, et al:
5alpha-reductase type 2 gene variant associations with prostate
cancer risk, circulating hormone levels and androgenetic alopecia.
Int J Cancer. 120:776–780. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Makridakis NM, Ross RK, Pike MC, et al:
Association of mis-sense substitution in SRD5A2 gene with prostate
cancer in African-American and Hispanic men in Los Angeles, USA.
Lancet. 354:975–978. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ross RK, Pike MC, Coetzee GA, et al:
Androgen metabolism and prostate cancer: establishing a model of
genetic susceptibility. Cancer Res. 58:4497–4504. 1998.PubMed/NCBI
|
|
18
|
Ji G, Gu A, Xia Y, et al: ERCC1 and ERCC2
polymorphisms and risk of idiopathic azoospermia in a Chinese
population. Reprod Biomed Online. 17:36–41. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Osborne EC, Lynch M, McLachlan R, Trounson
AO and Cram DS: Microarray detection of Y chromosome deletions
associated with male infertility. Reprod Biomed Online. 15:673–680.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Larsen L, Scheike T, Jensen TK, et al:
Computer-assisted semen analysis parameters as predictors for
fertility of men from the general population. The Danish First
Pregnancy Planner Study Team. Hum Reprod. 15:1562–1567. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barrett JC, Fry B, Maller J and Daly MJ:
Haploview: analysis and visualization of LD and haplotype maps.
Bioinformatics. 21:263–265. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Menkveld R, Wong WY, Lombard CJ, et al:
Semen parameters, including WHO and strict criteria morphology, in
a fertile and subfertile population: an effort towards
standardization of in-vivo thresholds. Hum Reprod. 16:1165–1171.
2001. View Article : Google Scholar
|
|
23
|
Payne AH, Kawano A and Jaffe RB: Formation
of dihydrotestosterone and other 5 alpha-reduced metabolites by
isolated seminiferous tubules and suspension of interstitial cells
in a human testis. J Clin Endocrinol Metab. 37:448–453. 1973.
View Article : Google Scholar
|
|
24
|
Lindstrom S, Adami HO, Balter KA, et al:
Inherited variation in hormone-regulating genes and prostate cancer
survival. Clin Cancer Res. 13:5156–5161. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ntais C, Polycarpou A and Ioannidis JP:
SRD5A2 gene polymorphisms and the risk of prostate cancer: a
meta-analysis. Cancer Epidemiol Biomarkers Prev. 12:618–624.
2003.PubMed/NCBI
|
|
26
|
Cicek MS, Conti DV, Curran A, et al:
Association of prostate cancer risk and aggressiveness to androgen
pathway genes: SRD5A2, CYP17, and the AR. Prostate. 59:69–76. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Salam MT, Ursin G, Skinner EC, Dessissa T
and Reichardt JK: Associations between polymorphisms in the steroid
5-alpha reductase type II (SRD5A2) gene and benign prostatic
hyperplasia and prostate cancer. Urol Oncol. 23:246–253. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pearce CL, Makridakis NM, Ross RK, et al:
Steroid 5-alpha reductase type II V89L substitution is not
associated with risk of prostate cancer in a multiethnic population
study. Cancer Epidemiol Biomarkers Prev. 11:417–418.
2002.PubMed/NCBI
|
|
29
|
Elzanaty S, Giwercman YL and Giwercman A:
Significant impact of 5alpha-reductase type 2 polymorphisms on
sperm concentration and motility. Int J Androl. 29:414–420. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Peters M, Saare M, Kaart T, et al:
Analysis of polymorphisms in the SRD5A2 gene and semen parameters
in Estonian men. J Androl. 31:372–378. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mahony MC, Swanlund DJ, Billeter M,
Roberts KP and Pryor JL: Regional distribution of 5alpha-reductase
type 1 and type 2 mRNA along the human epididymis. Fertil Steril.
69:1116–1121. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Berthaut I, Mestayer C, Portois MC,
Cussenot O and Mowszowicz I: Pharmacological and molecular evidence
for the expression of the two steroid 5 alpha-reductase isozymes in
normal and hyperplastic human prostatic cells in culture. Prostate.
32:155–163. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Thigpen AE, Silver RI, Guileyardo JM,
Casey ML, McConnell JD and Russell DW: Tissue distribution and
ontogeny of steroid 5 alpha-reductase isozyme expression. J Clin
Invest. 92:903–910. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Robaire B and Viger RS: Regulation of
epididymal epithelial cell functions. Biol Reprod. 52:226–236.
1995. View Article : Google Scholar
|
|
35
|
Mahendroo MS, Cala KM, Hess DL and Russell
DW: Unexpected virilization in male mice lacking steroid 5
alpha-reductase enzymes. Endocrinology. 142:4652–4662.
2001.PubMed/NCBI
|
|
36
|
Cornwall GA: New insights into epididymal
biology and function. Hum Reprod Update. 15:213–227. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Anderson RA, Kelly RW and Wu FC:
Comparison between testosterone enanthate-induced azoospermia and
oligozoospermia in a male contraceptive study. V Localization of
higher 5 alpha-reductase activity to the reproductive tract in
oligozoospermic men administered supraphysiological doses of
testosterone. J Androl. 18:366–371. 1997.
|
|
38
|
Henderson NA and Robaire B: Effects of
PNU157706, a dual 5alpha-reductase inhibitor, on rat epididymal
sperm maturation and fertility. Biol Reprod. 72:436–443. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cai LQ, Fratianni CM, Gautier T and
Imperato-McGinley J: Dihydrotestosterone regulation of semen in
male pseudohermaphrodites with 5 alpha-reductase-2 deficiency. J
Clin Endocrinol Metab. 79:409–414. 1994.PubMed/NCBI
|
|
40
|
Amory JK, Wang C, Swerdloff RS, et al: The
effect of 5alpha-reductase inhibition with dutasteride and
finasteride on semen parameters and serum hormones in healthy men.
J Clin Endocrinol Metab. 92:1659–1665. 2007. View Article : Google Scholar : PubMed/NCBI
|
